Rfg Advisory, LLC Ionis Pharmaceuticals Inc Transaction History

Rfg Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 22, 2020	SELL	$53.85 - $65.27 $219,815 - $266,432	-4,082 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$59.06 - $72.15 $42,995 - $52,525	728 Added 21.71%	4,082 $245,000
Q2 2019 Aug 23, 2019	BUY	$62.09 - $86.14 $4,967 - $6,891	80 Added 2.44%	3,354 $214,000
Q2 2019 Aug 15, 2019	BUY	$62.09 - $86.14 $203,282 - $282,022	3,274 New	3,274 $209,000

404

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Rfg Advisory, LLC with notifications on news.